Navigating the Health Horizon: Key Insights from Brussels Summit
The recent Euronews Health Summit in Brussels served as a crucial forum for top political and business leaders in the health sector to grapple with the most pressing challenges facing global health. Discussions ranged from persistent medicine shortages and the pursuit of European health sovereignty to the complex ethical considerations surrounding artificial intelligence (AI) in healthcare.
The summit underscored that health remains a paramount concern, a sentiment echoed by Olivér Várhelyi, a European Commissioner. He articulated a vision for a future where innovation flourishes and life-saving treatments reach patients more rapidly. “By simplifying what should be simplified, implementing and enforcing, and updating our rules, we move further towards the future we want. A future where innovation thrives, and ideas are turned into treatments much faster,” Várhelyi stated. This commitment is being translated into action through significant legislative updates, including the EU Biotech Act and a comprehensive overhaul of the bloc’s pharmaceutical regulations, aimed at streamlining processes and fostering a more dynamic health landscape. Várhelyi emphasised, “Health, I think, is still the biggest challenge in front of us for Europe, but also for the part of the world we are living in.”
A United Front Against Shared Threats
The Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, highlighted the interconnected nature of global health crises. He pointed to a confluence of challenges, including ongoing conflicts, mass displacement, widespread poverty, the rising burden of non-communicable diseases, significant mental health struggles, and the persistent threat of antimicrobial resistance. “None of these dangers can be managed in isolation. Shared threats demand a shared response,” Ghebreyesus asserted. He also provided an update on the WHO’s recent period of recalibration, noting that following a “difficult process of prioritisation and realignment,” the organisation has achieved a stable footing and is now operating with enhanced effectiveness and efficiency.
The Perils of Protectionism and the Promise of Innovation
The COVID-19 pandemic starkly exposed vulnerabilities in global health systems, prompting a strategic reorientation within the EU towards enhanced crisis preparedness, reduced dependencies, and bolstered competitiveness. Olivier Girard, Head of Unit Medical Counter Measures at DG HERA, distilled a key takeaway from this experience: “Protectionism doesn’t work. We have to have access to the right medicine, the one that helps fight the threat that is going to happen — innovation is very important for that. We want diversity, and cutting-edge innovation to be able to be prepared for the next crisis.” This sentiment underscores the critical need for an open and collaborative approach to medical advancements and supply chains.
Forging the Future of AI in Healthcare
The integration of AI into healthcare presents both immense opportunities and complex ethical dilemmas. Ricardo Baptista Leite, CEO at HealthAI, observed the divergent funding models for AI in healthcare across different regions, noting the predominantly private sector-driven approach in the United States and the state-led initiatives in China. He proposed a distinct European model: “I think this is actually the biggest opportunity for Europe, which is to be right in the middle, to bring together the public and the private sectors to work together.” Baptista Leite urged European institutions to foster closer collaboration with the private sector to unlock the full potential of AI in health.
However, this technological advancement must be guided by stringent ethical considerations. Fulvia Raffaelli, head of unit for Digital Health at DG SANTE within the European Commission, stressed the non-negotiable boundary: “I think the line that we should not cross is the one that puts at stake the safety of the patient and the people.” She emphasised the ongoing need to collaboratively define these ethical guardrails, ensuring that innovators developing AI tools work in tandem with users and directly benefit patients.
Jan-Willem Scheijgrond, vice president and global head of government and public affairs at Philips, acknowledged the nascent stage of AI adoption in healthcare, stating, “I think we’ve started, so we’ve crossed the starting line with AI, but the challenge is we’re on a journey that we’re actually not quite sure where we’re all going.” He underscored the importance of ensuring AI’s relevance and its ability to improve patient access and societal well-being. Drawing parallels with historical technological advancements, Scheijgrond noted the necessity of establishing and continually reassessing safety protocols, much like the evolution of safety standards for X-rays.
Prioritising Prevention and Early Intervention
The summit also shone a spotlight on the critical importance of preventative healthcare. Lydia Abad-Franch, senior vice president and head of research, development, and medical affairs at Sobi, a Swedish biopharmaceutical company, advocated for a proactive approach, particularly in managing kidney diseases. “The best dialysis is no dialysis, and the best kidney replacement therapy is not to need kidney replacement therapies,” she declared. Abad-Franch highlighted the significant economic, emotional, and socioeconomic costs associated with late diagnoses, stressing the urgent need for enhanced awareness, early intervention, education, and global awareness campaigns to reach at-risk populations sooner.
Health as a Strategic Imperative
Milka Sokolović, director general of the European Public Health Alliance (EPHA), reinforced the notion of health as a fundamental strategic asset. “If health systems are in trouble, everything else collapses, societies are suffering, and everything else is suffering,” she asserted. Sokolović emphasised that regardless of where health competencies reside – within the EU or national governments – the ultimate measure of success lies in the quality of healthcare delivery reaching patients.
Addressing the Growing Mental Health Crisis
The Health Minister of the Czech Republic, Adam Vojtěch, underscored the government’s commitment to health as a top priority, recognising its foundational role in societal resilience. He noted the intrinsic link between national defence and security and the imperative of maintaining a healthy and resilient population, encompassing both physical and mental well-being. Vojtěch expressed grave concern over the deteriorating mental health landscape, particularly among younger generations, calling for concerted action from both national governments and the EU to address this escalating issue.
